First published

Kadant: can replacement parts outlast acquisition-driven growth?

Correction

Not assessable

Outcome updated

17 November KAI historical vendor price comparison; supersedes only the earlier note's timing explanation, not the forecast

What we originally said
MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9].
What actually happened

Correction: For 17 November 2026, Stock Analysis lists a $286.79 close; MarketBeat's daily table labels $286.89 its closing price. The cited records do not establish a 15:59 EST trade or explain the $0.10 difference. We withdraw the one-minute-earlier explanation, including its repetition in the earlier correction.

What we learned

We retain $286.79 as the attributed Stock Analysis historical tracking mark. Neither figure is an executable quote or an actual entry. The operating thesis and six review dates are unchanged.

What remains uncertain

The original MarketBeat page capture is unavailable, and the reason for the vendors' $0.10 difference is not established. The price data do not establish a purchase or realized return.

What we will check next

Recover the original timestamped source receipt or a comparable independent historical market record before asserting a cause for the difference.

Why we changed this note

The cited MarketBeat daily table labels $286.89 as its closing price, and the cited records do not substantiate the stated 15:59 observation.

Supporting evidence
  • Kadant historical price dataEvent · Checked Primary source · Public accessEvidence limits Rolling page; publication date unknown.
  • Kadant price historyEvent · Checked Independent evidence · Public accessEvidence limits Rolling page; current table labels the amount closing price and does not provide a 15:59 timestamp.

Read the earlier note

Review overdue · no later published assessment recorded · Planned

Source repair ·

See the later correction

Source repair

Source repair

Update published

This repairs a source reference. It does not establish a new outcome.

K7 and K9 source-date labels, not the original forecast or price observations

What we originally said
MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9].
What actually happened

Correction: the 17 November dates displayed as publication dates for the Stock Analysis and MarketBeat pages are the dates of the price observations, not verified publication dates of those rolling webpages.

What we learned

The $286.79 historical close and $286.89 earlier observation remain dated market observations, not executable prices or evidence of a trade.

What remains uncertain

The original publication dates of those rolling webpages are not established.

What we will check next

A precision-aware citation field or independently datelined record would permit the underlying metadata to be corrected.

Supporting evidence
  • Kadant historical price dataEvent · Checked Primary source · Public accessEvidence limits Rolling page; its original webpage publication date is unknown.
  • Kadant price chartEvent · Checked Independent evidence · Public accessEvidence limits Rolling page; chart observation time is not a webpage publication date.

Explore cases in OTR Learns · See the public outcome record

Explore this signal

Long Term at a glance

Short reader summary

Kadant sold $218.4 million of parts and consumables in a quarter. How much came from customers returning to service existing machines? The filings do not say. Organic orders, margins and cash after investment offer a way to test that idea as acquired growth rolls off.

Exact asset or item

Kadant Inc. common shares (NYSE: KAI), United States, USD

Asset type

Listed investment

Reference price

286.79

Currency code

USD

Price observed at

2026-11-17T16:00:00-05:00

What this number represents

Tracking price

What remains unproven

Kadant Inc. common shares, NYSE: KAI, USD. Historical share-price observation: $286.79 at the regular US session close on 17 Nov 2026 at 16:00 EST (18 Nov 05:00 SGT), a vendor-recorded NYSE-listed close [K7]. MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9]. Neither observation is a current offer, actual purchase or claim of fair value. A broker’s executable price, account eligibility and all-in FX and dealing costs were not verified.

Exact asset or item

Exact asset or item

Kadant Inc. common shares (NYSE: KAI), United States, USD

Asset type

Listed investment

Ticker

KAI

Exchange

NYSE

How to identify this exact asset

Imagine a paper mill that has already bought an expensive machine. When a working part wears out, the mill has a reason to buy a replacement even if it does not buy another machine. Kadant supplies capital equipment along with replacement parts and consumables. Its installed base can therefore support recurring demand. But a part is not a subscription: factories can cut shifts, delay maintenance purchases, change suppliers or negotiate prices [K2].

Price and what it means

Entry or reference price

286.79

Currency code

USD

Price observed at

2026-11-17T16:00:00-05:00

What this number represents

Tracking price

Price evidence status

Indicative

Price source

K7 | 17 Nov 2026 NY regular close | Market-data row: USD open 285.35, high 292.13, low 283.97, close 286.79. Event/research time distinct.

Publisher: Stock Analysis

published date precision: day

Source publication date 2026-11-17

Matching price source ID

K7

Purchase, sale and realised profit

No purchase, sale, executable entry or realized return was established.

The developments we connected

Separate development

  1. What changed

    Q2: reported and organic bookings diverged

    Date of the development

    Evidence status

    Observed

    What the evidence shows

    In Q2 bookings rose 16% overall but fell 1% organically; acquisitions and currency added to reported growth [K3].

    Source IDs

    • K3
  2. What changed

    Q3: organic bookings improved

    Date of the development

    Evidence status

    Observed

    What the evidence shows

    Kadant disclosed Q3 results on 3 Nov at 16:39 EST (21:39 UTC). On 10 Nov it filed the quarter’s 10-Q. These are earlier disclosures newly examined in this 19 Nov source, not a fresh earnings announcement today. Q3 bookings rose 22% year over year to $291.1m; management calculated 10% organic bookings growth, with acquisitions adding 12 percentage points. Revenue rose 15% to $313.2m, with 4% organic growth. Bookings divided by revenue was about 0.93. Orders and revenue relate to different cohorts; this ratio neither establishes cancellations nor predicts the next quarter’s cash [K1,K2].

    Source IDs

    • K1
    • K2

Emerging insight

The question for a shareholder is whether older machines keep earning enough from wear parts AFTER acquired growth no longer boosts year-on-year comparisons. A move in the group’s quoted shares cannot answer that question.

How this exact asset could benefit

Original thesis: Kadant’s installed machinery may generate durable replacement-part demand as acquired businesses roll into comparable results. A sustained gain requires organic orders and repeatedly positive cash after capital spending without persistent margin erosion; reported growth alone is not evidence.

Who could benefit

  1. Who

    Kadant common shareholders

    How they could benefit

    Additional parts earnings must survive operating costs, capital needs, taxes, financing and dilution before owners benefit. The share price paid also matters.

    Evidence status

    Still unproven

What we observed

In the quarter ended 3 October, its parts and consumables generated $218.4m of revenue versus $188.4m the prior year [K2]. That is group-wide revenue, not an audited measure of repeat purchases by the same customers. On 30 April Kadant acquired Böhler Profil, which makes specialty profiles including material used for industrial knives. Its newly consolidated sales and orders can increase reported growth even if older businesses gain little. Both buyer and seller report the transaction; they do not establish contract-level proceeds from replacement parts [K2,K5,K6].

Kadant disclosed Q3 results on 3 Nov at 16:39 EST (21:39 UTC). On 10 Nov it filed the quarter’s 10-Q. These are earlier disclosures newly examined in this 19 Nov source, not a fresh earnings announcement today. Q3 bookings rose 22% year over year to $291.1m; management calculated 10% organic bookings growth, with acquisitions adding 12 percentage points. Revenue rose 15% to $313.2m, with 4% organic growth. Bookings divided by revenue was about 0.93. Orders and revenue relate to different cohorts; this ratio neither establishes cancellations nor predicts the next quarter’s cash [K1,K2].

In Q2 bookings rose 16% overall but fell 1% organically; acquisitions and currency added to reported growth [K3]. The contrast makes Q3’s organic improvement worth tracking, not proven durable. Q3 gross margin slipped from 45.2% to 44.7%. Operating cash flow was $62.9m versus $47.3m; Kadant’s non-GAAP free cash flow was $58.1m versus $44.1m. Neither can be attributed to recent orders or the Austrian business from these disclosures [K1]. In fiscal 2025 adjusted EBITDA fell to $216.3m from $229.7m, a warning against extrapolating the record quarter [K4].

What remains unproven

Original public news comes from issuer/SEC and seller; neither an earnings release nor a macro indicator supplies independent evidence that a particular customer reordered. Source recheck: 19 Nov 2026 SGT. Undisclosed: named repeated purchaser cohort, segment-level cash, live broker ticket and investor fees.

Reported growth is not organic growth
Reported growth is not organic growth
Bookings growth, year over yearQ2 2026Q3 2026
Reported+16%+22%
Organic−1%+10%
Different quarters; acquisitions and currency contribute to reported growth.
Sources

What to check before acting

Entry conditions

Kadant Inc. common shares, NYSE: KAI, USD. Historical share-price observation: $286.79 at the regular US session close on 17 Nov 2026 at 16:00 EST (18 Nov 05:00 SGT), a vendor-recorded NYSE-listed close [K7]. MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9]. Neither observation is a current offer, actual purchase or claim of fair value. A broker’s executable price, account eligibility and all-in FX and dealing costs were not verified.

Possible upside

Repeated profitable replacement demand could support cash available to owners, if organic growth persists after acquisition comparisons normalize.

Possible downside

The buyer recorded a $170.2m net acquisition price [K2]. To benefit owners, any additional parts earnings must survive freight, labor, inventory financing, investment and taxes. A full order book coupled with weak cash, shrinking margins, or acquisitions funded with costly debt could leave shareholders worse off. Broad US manufacturing output rose 0.3% in October, but was down 0.1% excluding motor vehicles and parts. Neither national measure tells us how an individual Kadant customer ran its machines [K8].

Price or return range method

Illustration only: ten shares at the historical mark imply $2,867.90 before costs. At a hypothetical $5 fee to buy and $5 to sell, break-even would be $287.79 per share before spreads, taxes, dividends or FX. The assumed fees are not an actual broker quote. Selling below a quoted mark, exchange-rate changes or paying too high a valuation can defeat a sound business thesis.

Costs and fees

Illustration only: ten shares at the historical mark imply $2,867.90 before costs. At a hypothetical $5 fee to buy and $5 to sell, break-even would be $287.79 per share before spreads, taxes, dividends or FX. The assumed fees are not an actual broker quote. Selling below a quoted mark, exchange-rate changes or paying too high a valuation can defeat a sound business thesis.

How hard it may be to sell

NYSE listing provides a trading venue, not a guaranteed fill at the historical close. No executable broker price or account eligibility was verified.

Key risks

Action now: track bookings, organic growth, parts revenue, gross margin and cash after capex on the same reporting calendar. Record acquisition anniversaries. Upside needs repeated profitable demand, not a single record. Downside includes cheaper alternative parts, factory downtime, lumpy capital-equipment awards, leverage and dilution; price risk remains even if operating cash improves.

What an ordinary reader can do next

Action now: track bookings, organic growth, parts revenue, gross margin and cash after capex on the same reporting calendar. Record acquisition anniversaries. Upside needs repeated profitable demand, not a single record. Downside includes cheaper alternative parts, factory downtime, lumpy capital-equipment awards, leverage and dilution; price risk remains even if operating cash improves.

What must reach shareholders?
  1. OrdersSeparate organic demand from acquisitions and currency
  2. CashCompare operating cash after capital spending and margins
  3. Owner outcomeCheck leverage, dilution and entry costs separately
An increase in orders alone does not establish shareholder profit.
Sources

Original forecast record

Original forecast in full

Will yesterday’s machines bring tomorrow’s orders?

Kadant Inc. common shares, NYSE: KAI, USD. Historical share-price observation: $286.79 at the regular US session close on 17 Nov 2026 at 16:00 EST (18 Nov 05:00 SGT), a vendor-recorded NYSE-listed close [K7]. MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9]. Neither observation is a current offer, actual purchase or claim of fair value. A broker’s executable price, account eligibility and all-in FX and dealing costs were not verified.

Imagine a paper mill that has already bought an expensive machine. When a working part wears out, the mill has a reason to buy a replacement even if it does not buy another machine. Kadant supplies capital equipment along with replacement parts and consumables. Its installed base can therefore support recurring demand. But a part is not a subscription: factories can cut shifts, delay maintenance purchases, change suppliers or negotiate prices [K2].

In the quarter ended 3 October, its parts and consumables generated $218.4m of revenue versus $188.4m the prior year [K2]. That is group-wide revenue, not an audited measure of repeat purchases by the same customers. On 30 April Kadant acquired Böhler Profil, which makes specialty profiles including material used for industrial knives. Its newly consolidated sales and orders can increase reported growth even if older businesses gain little. Both buyer and seller report the transaction; they do not establish contract-level proceeds from replacement parts [K2,K5,K6].

The question for a shareholder is whether older machines keep earning enough from wear parts AFTER acquired growth no longer boosts year-on-year comparisons. A move in the group’s quoted shares cannot answer that question.

Three numbers that cannot be substituted

Kadant disclosed Q3 results on 3 Nov at 16:39 EST (21:39 UTC). On 10 Nov it filed the quarter’s 10-Q. These are earlier disclosures newly examined in this 19 Nov source, not a fresh earnings announcement today. Q3 bookings rose 22% year over year to $291.1m; management calculated 10% organic bookings growth, with acquisitions adding 12 percentage points. Revenue rose 15% to $313.2m, with 4% organic growth. Bookings divided by revenue was about 0.93. Orders and revenue relate to different cohorts; this ratio neither establishes cancellations nor predicts the next quarter’s cash [K1,K2].

In Q2 bookings rose 16% overall but fell 1% organically; acquisitions and currency added to reported growth [K3]. The contrast makes Q3’s organic improvement worth tracking, not proven durable. Q3 gross margin slipped from 45.2% to 44.7%. Operating cash flow was $62.9m versus $47.3m; Kadant’s non-GAAP free cash flow was $58.1m versus $44.1m. Neither can be attributed to recent orders or the Austrian business from these disclosures [K1]. In fiscal 2025 adjusted EBITDA fell to $216.3m from $229.7m, a warning against extrapolating the record quarter [K4].

The buyer recorded a $170.2m net acquisition price [K2]. To benefit owners, any additional parts earnings must survive freight, labor, inventory financing, investment and taxes. A full order book coupled with weak cash, shrinking margins, or acquisitions funded with costly debt could leave shareholders worse off. Broad US manufacturing output rose 0.3% in October, but was down 0.1% excluding motor vehicles and parts. Neither national measure tells us how an individual Kadant customer ran its machines [K8].

Illustration only: ten shares at the historical mark imply $2,867.90 before costs. At a hypothetical $5 fee to buy and $5 to sell, break-even would be $287.79 per share before spreads, taxes, dividends or FX. The assumed fees are not an actual broker quote. Selling below a quoted mark, exchange-rate changes or paying too high a valuation can defeat a sound business thesis.

Six dated tests

Original thesis: Kadant’s installed machinery may generate durable replacement-part demand as acquired businesses roll into comparable results. A sustained gain requires organic orders and repeatedly positive cash after capital spending without persistent margin erosion; reported growth alone is not evidence.

6 MONTHS · 19 May 2027. Compare the next two available quarterly booking, revenue and organic-growth disclosures with their own prior-year periods. Separate acquired growth and exchange effects. Check whether orders lag sales in successive periods rather than declaring failure from one ratio.

1 YEAR · 19 Nov 2027. After the Böhler acquisition anniversary, compare parts/consumables with capital-equipment growth where reported. An increase from a larger consolidated base is not proof of replacement sales to existing customers. If cohort data remain undisclosed, say so.

2 YEARS · 19 Nov 2028. Main test: assess two full-year records of organic demand, gross margin, operating cash and cash after actual capital spending. If sales rise but margins and cash persistently weaken, the proposed replacement-parts advantage is contradicted. If parts-level cash is not disclosed, do not assign group cash to that segment.

3 YEARS · 19 Nov 2029. Compare cumulative available cash and leverage/diluted shares with acquisition and financing costs. Keep the $170.2m transaction separate from subsequent deals; if incremental returns are not disclosed, cannot conclude it paid for itself.

4 YEARS · 19 Nov 2030. Compare replacement demand with equipment demand across a documented industrial slowdown; keep pricing and mix distinct from units if disclosed. Without such a period or disaggregated data, resilience remains untested.

5 YEARS · 19 Nov 2031. Judge repeat cash per diluted share across observed periods separately from total shareholder return. Include actual costs and dividends only when documented. No trade means no realized return.

Action now: track bookings, organic growth, parts revenue, gross margin and cash after capex on the same reporting calendar. Record acquisition anniversaries. Upside needs repeated profitable demand, not a single record. Downside includes cheaper alternative parts, factory downtime, lumpy capital-equipment awards, leverage and dilution; price risk remains even if operating cash improves.

Original forecast date and time

2026-11-19T01:17:06+08:00

Parts and consumables revenueUSD millions
Horizontal scale 0 to 250Ticks 0 · 50 · 100 · 150 · 200 · 250
View chart values
Parts and consumables revenue
QuarterRevenue
Q3 2025188.4
Q3 2026218.4
Group revenue is not proof of repeat purchases by the same customers.
Sources

Forecasts and review dates

6 months

Review date

2027-05-19

Original forecast

6 MONTHS · 19 May 2027. Compare the next two available quarterly booking, revenue and organic-growth disclosures with their own prior-year periods. Separate acquired growth and exchange effects. Check whether orders lag sales in successive periods rather than declaring failure from one ratio.

What to measure

Bookings and revenue versus prior year; organic versus acquired growth and FX.

What must happen

Organic orders hold up beyond a single quarter.

What would challenge the forecast

Orders repeatedly lag sales while organic demand weakens.

Current outcome

Not yet due

1 year

Review date

2027-11-19

Original forecast

1 YEAR · 19 Nov 2027. After the Böhler acquisition anniversary, compare parts/consumables with capital-equipment growth where reported. An increase from a larger consolidated base is not proof of replacement sales to existing customers. If cohort data remain undisclosed, say so.

What to measure

Parts versus equipment growth after the acquisition anniversary.

What must happen

Comparable evidence separates replacement demand from acquired sales.

What would challenge the forecast

Acquisition-driven sales alone leave repeat demand unproven.

Current outcome

Not yet due

2 years

Review date

2028-11-19

Original forecast

2 YEARS · 19 Nov 2028. Main test: assess two full-year records of organic demand, gross margin, operating cash and cash after actual capital spending. If sales rise but margins and cash persistently weaken, the proposed replacement-parts advantage is contradicted. If parts-level cash is not disclosed, do not assign group cash to that segment.

What to measure

Two full years of organic demand, gross margin, operating cash and capital spending.

What must happen

Organic demand and positive cash after capex persist without sustained margin erosion.

What would challenge the forecast

Rising sales alongside persistently weaker margins and cash contradict the thesis.

Current outcome

Not yet due

3 years

Review date

2029-11-19

Original forecast

3 YEARS · 19 Nov 2029. Compare cumulative available cash and leverage/diluted shares with acquisition and financing costs. Keep the $170.2m transaction separate from subsequent deals; if incremental returns are not disclosed, cannot conclude it paid for itself.

What to measure

Cumulative cash, leverage, financing costs and diluted shares.

What must happen

Cash gains survive acquisition and financing costs per diluted share.

What would challenge the forecast

Absent incremental returns, acquisition payback cannot be concluded.

Current outcome

Not yet due

4 years

Review date

2030-11-19

Original forecast

4 YEARS · 19 Nov 2030. Compare replacement demand with equipment demand across a documented industrial slowdown; keep pricing and mix distinct from units if disclosed. Without such a period or disaggregated data, resilience remains untested.

What to measure

Replacement demand versus equipment demand in a documented slowdown.

What must happen

Comparable evidence shows resilient replacement demand during the slowdown.

What would challenge the forecast

No disaggregation or slowdown leaves resilience untested.

Current outcome

Not yet due

5 years

Review date

2031-11-19

Original forecast

5 YEARS · 19 Nov 2031. Judge repeat cash per diluted share across observed periods separately from total shareholder return. Include actual costs and dividends only when documented. No trade means no realized return.

What to measure

Cash per diluted share and separately documented shareholder return.

What must happen

Cash generation recurs on a diluted-share basis.

What would challenge the forecast

Dilution or weaker repeat cash erodes the operating case; no trade means no realized return.

Current outcome

Not yet due

Sources

Dated source

  1. Source ID

    K1

    What this source supports

    3 Nov 2026, 16:39 EST | Issuer Q3 release, reported/organic bridge and non-GAAP reconciliation.

  2. Source ID

    K2

    What this source supports

    Filed 10 Nov 2026 | SEC 10-Q for quarter ended 3 Oct: product revenues, demand, seasonality, transaction and risks. Company-authored.

  3. Source ID

    K3

    What this source supports

    4 Aug 2026, 16:37 EDT | Issuer Q2 release: 16% total bookings growth vs 1% organic decline; currency and acquisitions included in reported comparison.

  4. Source ID

    K4

    What this source supports

    18 Feb 2026, 17:03 EST | Fiscal-year 2025 and Q4 results | Company’s earlier full-year comparison, adjusted EBITDA is not cash.

  5. Source ID

    K5

    What this source supports

    Seller H1 FY2026/27, transaction effective 30 Apr 2026 | Seller consolidation note, not evidence of subsequent buyer receipts.

  6. Source ID

    K6

    What this source supports

    Seller H1 FY2026/27 | Seller describes the Bruckbach specialty-profile operation. Same seller as K5, not a third independent confirmation.

  7. Source ID

    K7

    What this source supports

    17 Nov 2026 NY regular close | Market-data row: USD open 285.35, high 292.13, low 283.97, close 286.79. Event/research time distinct.

  8. Source ID

    K8

    What this source supports

    17 Nov 2026 | Federal Reserve G.17: US industrial production for October, context not Kadant’s demand. See the dated 17 November 2026 entry in the Board’s release archive.

  9. Source ID

    K9

    What this source supports

    17 Nov 2026, 15:59 EST | MarketBeat intraday chart: $286.89, a minute before the regular close, not a conflicting simultaneous trade.

Source limits

Original public news comes from issuer/SEC and seller; neither an earnings release nor a macro indicator supplies independent evidence that a particular customer reordered. Source recheck: 19 Nov 2026 SGT. Undisclosed: named repeated purchaser cohort, segment-level cash, live broker ticket and investor fees.

Back to Signals

AI powered research